Sushan Luo

2.1k total citations
116 papers, 1.1k citations indexed

About

Sushan Luo is a scholar working on Neurology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Sushan Luo has authored 116 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Neurology, 30 papers in Molecular Biology and 18 papers in Infectious Diseases. Recurrent topics in Sushan Luo's work include Myasthenia Gravis and Thymoma (47 papers), Peripheral Neuropathies and Disorders (34 papers) and Antifungal resistance and susceptibility (17 papers). Sushan Luo is often cited by papers focused on Myasthenia Gravis and Thymoma (47 papers), Peripheral Neuropathies and Disorders (34 papers) and Antifungal resistance and susceptibility (17 papers). Sushan Luo collaborates with scholars based in China, United Kingdom and France. Sushan Luo's co-authors include Chongbo Zhao, Jianying Xi, Jiahong Lu, Wenhua Zhu, Jie Song, Huahua Zhong, Jie Lin, Chong Yan, Xiao Huan and Jian Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Sushan Luo

105 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sushan Luo China 19 541 334 149 137 124 116 1.1k
Amets Sáenz Spain 18 222 0.4× 522 1.6× 334 2.2× 93 0.7× 55 0.4× 41 949
Cyril Gitiaux France 20 256 0.5× 559 1.7× 89 0.6× 47 0.3× 66 0.5× 84 1.4k
Jiro Fukae Japan 19 690 1.3× 314 0.9× 273 1.8× 34 0.2× 40 0.3× 67 1.3k
John Kerrison United States 23 226 0.4× 588 1.8× 118 0.8× 28 0.2× 50 0.4× 46 1.6k
Sevim Erdem‐Özdamar Türkiye 15 343 0.6× 380 1.1× 321 2.2× 44 0.3× 23 0.2× 78 1.1k
Giacomo Lus Italy 19 259 0.5× 184 0.6× 54 0.4× 28 0.2× 32 0.3× 85 950
Jennifer A. Tracy United States 17 406 0.8× 189 0.6× 179 1.2× 40 0.3× 18 0.1× 46 968
Minako Beppu Japan 21 650 1.2× 167 0.5× 380 2.6× 23 0.2× 24 0.2× 49 1.0k
Guangyou Wang China 22 186 0.3× 347 1.0× 48 0.3× 20 0.1× 63 0.5× 62 1.3k
Malte Kornhuber Germany 18 389 0.7× 293 0.9× 305 2.0× 29 0.2× 19 0.2× 67 982

Countries citing papers authored by Sushan Luo

Since Specialization
Citations

This map shows the geographic impact of Sushan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushan Luo more than expected).

Fields of papers citing papers by Sushan Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sushan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushan Luo. The network helps show where Sushan Luo may publish in the future.

Co-authorship network of co-authors of Sushan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Sushan Luo. A scholar is included among the top collaborators of Sushan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sushan Luo. Sushan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Chong, Jian Sun, Jianying Xi, et al.. (2025). Ofatumumab for treating autoimmune nodopathy. Journal of the Peripheral Nervous System. 30(1). e12679–e12679. 2 indexed citations
2.
Zhou, Qian, Sushan Luo, Chong Yan, et al.. (2025). Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis. Therapeutic Advances in Neurological Disorders. 18. 4243607866–4243607866.
3.
Zhong, Huahua, Hongyu Zhou, Zhang‐Yu Zou, et al.. (2025). Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study. Clinical Immunology. 281. 110587–110587.
4.
5.
6.
Huan, Xiao, Sushan Luo, Huahua Zhong, et al.. (2024). Serum cytokines profile changes in amyotrophic lateral sclerosis. Heliyon. 10(7). e28553–e28553. 3 indexed citations
7.
Ruan, Zhe, et al.. (2024). A predictive nomogram for short‐term outcomes of myasthenia gravis patients treated with low‐dose rituximab. CNS Neuroscience & Therapeutics. 30(5). e14761–e14761. 1 indexed citations
8.
Tan, Song, Jian‐Quan Shi, Ying Liu, et al.. (2024). Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study. Therapeutic Advances in Neurological Disorders. 17. 4233590519–4233590519. 2 indexed citations
9.
Zhong, Huahua, Zhe Ruan, Chong Yan, et al.. (2023). Short-term outcome prediction for myasthenia gravis: an explainable machine learning model. Therapeutic Advances in Neurological Disorders. 16. 4223436064–4223436064. 10 indexed citations
10.
Chen, Sheng, Xiao Huan, Sushan Luo, et al.. (2023). Eomesodermin expression in CD4+T‐cells associated with disease progression in amyotrophic lateral sclerosis. CNS Neuroscience & Therapeutics. 30(4). e14503–e14503. 2 indexed citations
11.
Huan, Xiao, Sushan Luo, Huahua Zhong, et al.. (2021). In‐depth peripheral CD4+ T profile correlates with myasthenic crisis. Annals of Clinical and Translational Neurology. 8(4). 749–762. 22 indexed citations
12.
Sun, Jian, Sushan Luo, Karen Suetterlin, et al.. (2021). Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations. Neuromuscular Disorders. 31(9). 829–838. 4 indexed citations
13.
Li, Nuo, et al.. (2020). The Synchronous Presence of Multiple Myelomas and Other Primary Malignant Tumors: Case Series with Literature Review. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Sun, Yi‐Min, Huiling Yu, Weixi Xiong, et al.. (2020). Disease Progression in Patients with Parkin‐Related Parkinson's Disease in a Longitudinal Cohort. Movement Disorders. 36(2). 442–448. 17 indexed citations
15.
Shen, Yan, Wenbo Yu, Bo Shen, et al.. (2020). Propagated α-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice. Brain. 143(11). 3374–3392. 52 indexed citations
16.
Song, Jie, Jianying Xi, Wenbo Yu, et al.. (2019). Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis. Clinical Immunology. 203. 142–153. 24 indexed citations
17.
Chen, Yang, Jianying Xi, Wenhua Zhu, et al.. (2018). GNE myopathy in Chinese population: hotspot and novel mutations. Journal of Human Genetics. 64(1). 11–16. 16 indexed citations
18.
Sun, Chong, Shuang Cai, Wenhua Zhu, et al.. (2018). A clinical and natural history research on mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. Chin J Neurol. 51(2). 118–123. 1 indexed citations
19.
Xi, Jianying, Gaëlle Blandin, Jiahong Lu, et al.. (2014). Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy. Neurology India. 62(6). 635–635. 24 indexed citations
20.
Xi, Jianying, Jiahong Lu, Chongbo Zhao, et al.. (2011). Clinical features and electron transfer flavoprotein dehydrogenase gene mutation analysis in 35 Chinese patients with lipid storage myopathy. Chin J Neurol. 44(5). 314–321. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amets Sáenz Breakdown of academic impact, for papers by Cyril Gitiaux Breakdown of academic impact, for papers by Jiro Fukae Breakdown of academic impact, for papers by John Kerrison Breakdown of academic impact, for papers by Sevim Erdem‐Özdamar Breakdown of academic impact, for papers by Giacomo Lus Breakdown of academic impact, for papers by Jennifer A. Tracy Breakdown of academic impact, for papers by Minako Beppu Breakdown of academic impact, for papers by Guangyou Wang Breakdown of academic impact, for papers by Malte Kornhuber
Rankless by CCL
2026